Huntington Bancshares Incorporated vs Immunovant Inc. Common Stock — how do they compare? Huntington Bancshares Incorporated trades at $15.31 (market cap $31.04B), while Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B). The key difference: Huntington Bancshares Incorporated is far larger — about 5× Immunovant Inc. Common Stock's market cap, and Huntington Bancshares Incorporated pays a 4.04% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Huntington Bancshares Incorporated for 52 Days and Immunovant Inc. Common Stock for 1 Days on average.
| HBAN | IMVT | |
|---|---|---|
Market Cap | $31.04B | $6.25B |
Volume | 23,864,172 | 1,755,411 |
Sector | Financials | Health |
52-Week High | $19.27 | $44.96 |
52-Week Low | $15.02 | $17.03 |
Typical Hold Time | 52 Days | 1 Days |
Enterprise Value | $49.57B | $5.35B |
Dividend Yield | 4.04% | — |
Signals from Pluang's Aura AI — not financial advice
Huntington Bancshares (HBAN) trades at $15.32, up 0.99% on the day, with a bearish technical signal and mixed earnings history. The company reported 2025 revenue of $8.13B and net income of $2.21B, with a P/E of 11.82 and ROE of 9.23%. Recent news highlights an increased prime rate to 7.00% and a revised 2027 earnings outlook due to margin pressures.
Outlook is cautious; analyst consensus is a Buy with a $19.60 price target, but near-term headwinds from higher interest rates and deposit costs pose risks. The stock offers value based on valuation metrics, yet investors should weigh margin pressures against shareholder return initiatives like the $550M buyback plan for 2026.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →